Identifying and Managing Pain in Cognitively Impaired Patients

Slideshow

How can clinicians determine the presence of pain in cognitively impaired patients? And how do you know the medication is working if your patient can’t tell you?

Related Videos
dementia
AfricaStudio/AdobeStock
Tierney/AdobeStock
Related Content
What is the efficacy of ECT for the treatment of dementia?

Electroconvulsive Therapy in Individuals with Behavioral and Psychological Symptoms of Dementia

April 22nd 2024
Article
What Will the Future of Alzheimer Disease Treatment Look Like?

What Will the Future of Alzheimer Disease Treatment Look Like?

July 23rd 2021
Podcast
The experts weighed in on a wide variety of psychiatric issues for the March 2024 issue of Psychiatric Times.

From the Pages of Psychiatric Times: March 2024

March 30th 2024
Article
Body Dysmorphic Disorder: Widespread and Potentially Deadly

Body Dysmorphic Disorder: Widespread and Potentially Deadly

March 24th 2021
Podcast
“If we can show that serotonin loss over time is directly involved in the transition from mild cognitive impairment to Alzheimer disease, recently developed antidepressant medications may be an effective way to improve memory deficits and depressive symptoms and, thus, may be a powerful way forward to slow disease progression.”

Mild Cognitive Impairment and Serotonin System Degeneration

March 14th 2024
Article
Two phase 3 trials were conducted to assess the clinical and biological effects as well as the safety of gantenerumab in individuals with mild cognitive impairment or mild dementia due to AD. Here's what you need to know.

Phase 3 Trials Examine Gantenerumab for Early Alzheimer Disease

February 20th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.